Liabilities / Assets
42nd percentile
Higher debt load relative to assets than 42% of similar nonprofits.
Simmaron Research Inc.
990 • Fiscal year 2016 • EIN 45-2191464
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.02x
Liabilities / Revenue
39th percentile
Higher debt load relative to revenue than 39% of similar nonprofits.
Net Margin
93rd percentile
Higher net margin than 93% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
96th percentile
Faster asset growth than 96% of similar nonprofits.
Revenue Growth
75th percentile
Faster revenue growth than 75% of similar nonprofits.
Balance Sheet
Assets
Up$452,594
Up $276,146 (+157%) from 2015
Net Assets
Up$444,474
Up $292,783 (+193%) from 2015
Liabilities
Down$8,120
Down $16,637 (-67%) from 2015
Revenue And Expenses
Revenue
Up$560,242
Up $98,721 (+21%) from 2015
Expenses
Down$267,459
Down $172,237 (-39%) from 2015
Net Income
Up$292,783
Up $270,958 (+1242%) from 2015
Historical Trend
Filing Detail Status
This 2016 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2016 to Dec 31, 2016
Mission and Program Overview
Mission
To conduct research on the etiology, pathogenesis, biomarkers, and treatment of myalgic encephelomyelitis (me) formerly know as chronic fatigue syndrome (cfs). Our mission statement is to scientifically redefine me/cfs.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2016 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $452,594
- Liabilities
- $8,120
- Net assets
- $444,474
- Revenue
- $560,242
- Expenses
- $267,459
- Net income
- $292,783